Disclaimers & References
ORSL®, ORSL® Advanz Care and WHO ORS Ready to Drink Product Range Disclaimers and References
ORSL® Electrolyte Drink Product Range Disclaimers and References :
Creative Visualization. Refer to product pack for complete details.
*1Basis IQVIA MAT Survey – Oct’ 23 – Sep ’24 for ORSL® Brand
*2Silent Dehydration refers to mild to moderate Non-Diarrheal Dehydration only. Please consult a Doctor/ Nutritionist for more information on Dehydration.
*3Scientific Facts Only
*4ORSL® delivers up to two times energy (in Kcal) as compared with a leading competing brand in a similar ready to drink category as applicable
*5Goodness of Vitamin C: Carr AC, Maggini S. Vitamin C and Immune Function. Nutrients. 2017 Nov 3;9(11):1211
Feel Better Faster Claim References: 1. Malve H et al. J Assoc Physicians India 2023;71(5):34-38 2. Reddy BR et al. J Assoc Physicians India 2024;72(6):39–56 3. Ghosh A et al. Int J Contemp; Pediatr. 2023;10(3):429-43
W.H.O. ORS Ready to Drink Product Range Disclaimers and References:
Creative Visualization. Refer to product pack for complete details.
1. RedkarM et al. J ApplPharm Sci. 2022;12(06):224-229; 2. As per product analysis report 2024; 3. Hahn S. et al. BMJ. 2001 Jul 14;323(7304):81–85. *Disclaimer - As per Study conducted in India, only 14.16% (<2 in 10 times) reconstituted solution resulted within WHO reduced osmolarity range. Laboratory testing of Kenvue WHO ORS RTD showed the osmolarity within WHO Reduced osmolarity range i.e. 100%. So (100/14.16)=7X. WHO reduced osmolarity ORS has shown better outcomes in terms of unscheduled IV fluids, vomiting, stool output etc.
Hydra Activ Technology: Physiological mechanism of sodium glucose transport at the cellular level in 1:1 ratio which enhances the water absorption thereby promoting effective hydration. "Hydra Active Technology," a term we have coined to make the mechanism more accessible and understandable to consumers.
7X Assured Osmolarity: As per an Indian study, when powder form of WHO ORS was reconstituted by caregivers of patient, > 8/10 times (85%) the reconstituted solution was not exactly as per WHO reduced osmolarity range and hence may result in poor outcomes from diarrheal dehydration. This means that only <2/10 times (15%) reconstituted solution was within reduced osmolarity range. Laboratory testing of Kenvue WHO ORS Ready-To-Drink formulation showed that osmolarity was 100% within WHO Reduced osmolarity range. 15% correct osmolarity with powder and 100% with RTD WHO ORS 100/15= Nearly 7). Hence, WHO ORS RTD is 7 times more likely to be within WHO Reduced osmolarity range as compared to powder form of WHO ORS. When WHO reduced osmolarity ORS was used it showed better outcomes in terms of unscheduled IV fluids, vomiting, stool output etc.
*6Osmolarity: Laboratory testing of Kenvue W.H.O ORS RTD showed the osmolarity within WHO recommended osmolarity range.
*7This is applicable to reduced osmolarity ORS. Implementing the New Recommendations on the Clinical Management of Diarrhoea. Guidelines for Policy Makers and Programme Managers By WHO & UNICEF Document. 2006. Available at https://tinyurl.com/uvmmp22m
93% deaths can be prevented with ORS Reference: Children <5 years with diarrhoea receiving oral rehydration therapy (ORT) and continued feeding. https://tinyurl.com/3r8xrwte
The Science Reference: Ann N Y Acad Sci. 2000;915:54-66